Extraordinary General Meeting to Approve Capital Reduction for Deficit Coverage
- Extraordinary general meeting to approve capital reduction (without payment) to cover accumulated deficits, to be held on June 9, 2026. Record date: May 12, 2026.
- Board resolution date: April 27, 2026, with all 2 outside directors present.
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)
- Company: NGeneBio (354200)
- Submission: NGeneBio Co., Ltd.
- Receipt: 04-27-2026
- Under KRX KOSDAQ Market Division